The goal of this study is to see how well therapy with the Eksobionic Exoskeleton (Esko) works for people with Parkinson's disease (PWPD). Esko is a robotic device that provides high repetition and intensity training. The investigators will examine its impact on walking, balance, and quality of life before, during and after an eight-week intervention program. The results will lay the groundwork for future trials, potentially leading to long-term improvements in mobility and quality of life for PWPD.
Physician diagnosed idiopathic Parkinson's disease
All Hoehn and Yahr (H&Y) stages will be eligible for inclusion in the study
Able to consent to participation in the research study
Pt agreeable to participate in 45-60 minutes of high intensity (RPE 14-17 for 30 minutes) gait training/ physical therapy.
Currently involved in another intervention study or physical therapy course of care
Concurrent neurological disease
Leg length discrepancy, self-reported.
Spinal instability
Albert Einstein Healthcare Network
Lead sponsor
Thomas Jefferson University
Sponsor institution
Moss Rehabilitation Research Institute
Collaborator